Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 18

1.

Application of cross-species PET imaging to assess neurotransmitter release in brain.

Finnema SJ, Scheinin M, Shahid M, Lehto J, Borroni E, Bang-Andersen B, Sallinen J, Wong E, Farde L, Halldin C, Grimwood S.

Psychopharmacology (Berl). 2015 Nov;232(21-22):4129-57. doi: 10.1007/s00213-015-3938-6. Epub 2015 Apr 30.

2.

Using the conditioned fear stress (CFS) animal model to understand the neurobiological mechanisms and pharmacological treatment of anxiety.

Li X.

Shanghai Arch Psychiatry. 2012 Oct;24(5):241-9. doi: 10.3969/j.issn.1002-0829.2012.05.001. Review.

3.

Mechanisms and environmental factors that underlying the intensification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced serotonin syndrome in rats.

Tao R, Shokry IM, Callanan JJ, Adams HD, Ma Z.

Psychopharmacology (Berl). 2015 Apr;232(7):1245-60. doi: 10.1007/s00213-014-3759-z. Epub 2014 Oct 11.

PMID:
25300903
4.

Effect of fluvoxamine on carrageenan-induced paw edema in rats evaluation of the action sites.

Hajhashemi V, Sadeghi H, Minaiyan M, Movahedian A, Talebi A.

Iran J Pharm Res. 2011 Summer;10(3):611-8.

5.

Lasting neurobehavioral abnormalities in rats after neonatal activation of serotonin 1A and 1B receptors: possible mechanisms for serotonin dysfunction in autistic spectrum disorders.

Khatri N, Simpson KL, Lin RC, Paul IA.

Psychopharmacology (Berl). 2014 Mar;231(6):1191-200. doi: 10.1007/s00213-013-3242-2. Epub 2013 Aug 24.

6.

Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT.

Descarries L, Riad M.

Philos Trans R Soc Lond B Biol Sci. 2012 Sep 5;367(1601):2416-25. doi: 10.1098/rstb.2011.0361. Review.

7.

Colocalization and regulated physical association of presynaptic serotonin transporters with A₃ adenosine receptors.

Zhu CB, Lindler KM, Campbell NG, Sutcliffe JS, Hewlett WA, Blakely RD.

Mol Pharmacol. 2011 Sep;80(3):458-65. doi: 10.1124/mol.111.071399. Epub 2011 Jun 24.

8.

Current therapeutic strategies for premature ejaculation and future perspectives.

Xin ZC, Zhu YC, Yuan YM, Cui WS, Jin Z, Li WR, Liu T.

Asian J Androl. 2011 Jul;13(4):550-7. doi: 10.1038/aja.2010.130. Epub 2011 May 2. Review.

9.

Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.

Nagayasu K, Yatani Y, Kitaichi M, Kitagawa Y, Shirakawa H, Nakagawa T, Kaneko S.

Br J Pharmacol. 2010 Dec;161(7):1527-41. doi: 10.1111/j.1476-5381.2010.00978.x.

10.

Differential effects of acute and repeated citalopram in mouse models of anxiety and depression.

Mombereau C, Gur TL, Onksen J, Blendy JA.

Int J Neuropsychopharmacol. 2010 Apr;13(3):321-34. doi: 10.1017/S1461145709990630. Epub 2009 Dec 14.

11.

Assessment of 5-hydroxytryptamine efflux in rat brain during a mild, moderate and severe serotonin-toxicity syndrome.

Zhang G, Krishnamoorthy S, Ma Z, Vukovich NP, Huang X, Tao R.

Eur J Pharmacol. 2009 Aug 1;615(1-3):66-75. doi: 10.1016/j.ejphar.2009.05.008. Epub 2009 May 20.

12.

Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortex.

Geldof M, Freijer JI, van Beijsterveldt L, Langlois X, Danhof M.

Br J Pharmacol. 2008 Jul;154(6):1369-78. doi: 10.1038/bjp.2008.179. Epub 2008 May 19.

13.

Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat.

Geldof M, Freijer J, van Beijsterveldt L, Danhof M.

Pharm Res. 2008 Apr;25(4):792-804. Epub 2007 Aug 21.

14.

CART peptides increase 5-hydroxytryptamine in the dorsal raphe and nucleus accumbens of freely behaving rats.

Ma Z, Pearson E, Tao R.

Neurosci Lett. 2007 May 7;417(3):303-7. Epub 2007 Feb 23.

15.

Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors.

Ceglia I, Acconcia S, Fracasso C, Colovic M, Caccia S, Invernizzi RW.

Br J Pharmacol. 2004 Jun;142(3):469-78. Epub 2004 May 17.

16.

Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effects.

Larsen AK, Brennum LT, Egebjerg J, Sánchez C, Halldin C, Andersen PH.

Br J Pharmacol. 2004 Mar;141(6):1015-23. Epub 2004 Mar 1.

18.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk